Protein S Activity, Antigen, Total and Free

Last Modified: 10/5/2022 11:11:22 AM


Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements: (2) 2.0 mL Plasma from a Blue Top Tubes - 3.2% Na Citrate in a Plastic Vials
Collection Instructions: Please submit a separate, frozen vial for each special coagulation assay ordered. 

Draw blood in a light blue-top tube containing 3.2% sodium citrate, mix gently by inverting 3-4 times.
Centrifuge 15 minutes at 1500 g within one hour of collection.
Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial.
Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial(s). 
Freeze immediately and transport on dry ice.
Minimum Volume: 0.5 mL Plasma (x2)
Transport & Storage: Temperature/Stability:

Unacceptable Amient
Unacceptable Refrigerated
30 days Frozen

Rejection Criteria: Hemolysis
Reference Range: See interperetive results 
Critical Ranges:  
Test Comments:  
Methodology: Clotting Assay • Immunoturbidimetric Assay
Clinical Significance: Protein S deficiency may either be hereditary or acquired and is associated with an increased risk for
venous thromboembolic disease. Congenital Protein S (PS) deficiency may be classified based on the PS Antigen (Free and Total) and activity results. Type I deficiency is characterized by a decrease in antigen and activity levels whereas a Type II deficiency will have normal antigen levels but reduced activity. A third classification, Type III deficiency, is characterized by reduced free PS antigen and activity, but normal total PS antigen levels associated with increased C4b binding protein level.

Anticoagulant interference: Expected impact by therapeutic levels (potential interference depends upon drug concentration): Vitamin K Antagonists (eg. warfarin): decrease; Heparin (UFH or LMWH): no effect to falsely increased activity levels at higher levels; Dabigatran or Argatroban (Thrombin Inhibitors): may falsely increase activity; Rivaroxaban, Apixaban, Edoxaban (Factor Xa Inhibitors): may falsely increase activity.
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Sites Performed: Quest - Chantilly
PHL Test Code: MSOT
EPIC Test Code: MISC
Send Out Test Code: 93355
Alternate Test Names: Protein S Functional; PS Antigen; PS Free
Included Tests: Protein S Antigen, Free; Proten S Antigen, Total; Protein S Activity
CPT Coding: 85305, 85306 (x2)

Go back to the top of the page.